Time to go fishing. Let's see how many American-Hating, Socialists we can catch with this bate.
The Food and Drug Administration has granted "breakthrough therapy" status for Novartis' (NYSE: NVS ) BYM338 drug, the company announced today, which could hasten regulatory review.
http://www.fool.com/investing/gener...ugh-therapy-status-could-hasten-novartis.aspx
Come on fishy, fishy, fishy...
The Food and Drug Administration has granted "breakthrough therapy" status for Novartis' (NYSE: NVS ) BYM338 drug, the company announced today, which could hasten regulatory review.
http://www.fool.com/investing/gener...ugh-therapy-status-could-hasten-novartis.aspx
Come on fishy, fishy, fishy...